We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Advanced Temperature Controller for Microfluidic Devices for Biotech Research Introduced

By LabMedica International staff writers
Posted on 30 Sep 2014
An innovative temperature controller for use in microfluidic applications is available for use by biotech and other life science researchers.

The microfluidics specialty company Dolomite (Royston, United Kingdom) introduced its new Meros TCU-100 temperature controller at the September 18–19, 2014, Lab-on-a-Chip & Microarray World Congress held in San Diego (CA, USA).

The Meros TCU-100 is the first module in the company's new Meros range of plug-and-play microfluidic products. More...
This line consists of a suite of integrated tools, specifically targeted at microfluidics users in research and education, with the ambition of providing a sophisticated suite of intelligently coordinated capabilities. The suite is be based around a modern touch-screen interface enabling clear visualization of data and virtual reconfiguration of the connected hardware such as pumps and valves. The intuitive and easy to use connections to microfluidic devices is be based on Dolomite’s existing range of microfluidic connectors, Multiflux.

The new Meros TCU-100 temperature controller, which offers advanced temperature control from 1–100 °C, was designed to accommodate a wide range of biological and chemical applications, including cell analysis, thermal control of microreactors, incubation of microdroplets, protein crystallization, nanoparticle synthesis, and thermocycling of micro-scale samples. The instrument is accurate within 0.5 °C with stability and target temperature resolution of 0.1 °C and rapid ramp rates up to 1 °C per second. Operation, data logging, and graphical data display are achieved through Dolomite’s user-friendly Flow Control Center software or third-party software.

“At Dolomite, we believe the scientist should be free to focus on science and not have to worry about finding the right tools for their job. That is why we will provide researchers with a next generation of plug and play microfluidic platforms for use in the laboratory,” said Andrew Lovatt, CEO of Dolomite. “Once again, Dolomite will apply its world-leading expertise in microfluidic solutions to development of innovative technologies.”

Related Links:

Dolomite



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The discovery of early markers for ovarian cancer that would have improved sensitivity could aid detection (Photo courtesy of Adobe Stock)

Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis

Ovarian cancer is a deadly and challenging disease, primarily because early detection is difficult. Most women (70-75%) are diagnosed only after the cancer has already spread, which significantly reduces... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.